Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach.

S GordonDavid L ChanE J BernardM E EslickKathy P WillowsonP J RoachA F EngelR MaherS J ClarkeV AgarwalL YasminM De SilvaS MascallAlice ConnerD NevellN PavlakisDale L Bailey

Published in: Journal of cancer research and clinical oncology (2023)

LUTATE treatment for NETs is a safe and effective treatment. Our approach relies heavily on functional and morphological imaging informing the multidisciplinary team of NET specialists to guide appropriate therapy, which we suggest has contributed to the favourable outcomes seen.

Keyphrases

palliative care
high resolution
quality improvement
type diabetes
combination therapy
mass spectrometry
bone marrow
metabolic syndrome
smoking cessation